Smart insulin pumps put to the test in everyday life

NCT ID NCT05418699

Completed Disease control Sponsor: Groupe Hospitalier de la Rochelle Ré Aunis Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 410 people with type 1 diabetes who use closed-loop insulin pumps—devices that automatically adjust insulin delivery. Researchers measured how well these pumps control blood sugar over time using HbA1c levels. The goal was to see if the pumps work effectively outside of controlled research settings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: closed-loop insulin pump
What this could lead to: If successful, this could show that closed-loop pumps improve blood sugar control in real-world settings, helping guide better diabetes management.
What could go wrong: This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES

Contacts and locations

Locations

CH Boulogne-sur-Mer

Boulogne-sur-Mer, France
CH Béthune-Beuvry

Béthune, France
CH Dax

Dax, France
CH Périgueux

Périgueux, France
CHI Mont de Marsan et du Pays des Sources

Mont-de-Marsan, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.